New Watercress Variety Shows Enhanced Health Benefits in Longer Growth Trials
Greg Howard
16th June, 2024
The 'Boldrewood' accession of Nasturtium officinale consistently demonstrates its dwarf phenotype, appearing visibly shorter and more compact than the commercial control variety from the seedling stage through to harvest.
Key Findings
- The University of Southampton developed a new watercress variety called 'Boldrewood' with a dwarf phenotype, making it more convenient for consumers
- Boldrewood watercress has a similar antioxidant capacity to commercial watercress, ensuring it retains health benefits
- Boldrewood has higher glucosinolate levels, which may enhance its cancer-preventive properties compared to standard watercress
References
Main Study
1) Characterization of a new dwarf watercress (Nasturtium officinale R Br.) ‘Boldrewood’ in commercial trials reveals a consistent increase in chemopreventive properties in a longer-grown crop
Published 15th June, 2024
https://doi.org/10.1007/s10681-024-03360-z
Related Studies
2) The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay.
Journal: Analytical biochemistry, Issue: Vol 239, Issue 1, Jul 1996
3) Systematic Review on the Metabolic Interest of Glucosinolates and Their Bioactive Derivatives for Human Health.
4) Natural product-derived antitumor compound phenethyl isothiocyanate inhibits mTORC1 activity via TSC2.
5) Acute and chronic watercress supplementation attenuates exercise-induced peripheral mononuclear cell DNA damage and lipid peroxidation.



30th May, 2024 | Greg Howard